Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 57 of 98, showing 5 Applications out of 486 total, starting on record 281, ending on 285

# Protocol No Study Title Investigator(s) & Site(s)

281.

ECCT/19/04/03   Phase III pediatric study with the L-PZQ ODTs
    An Open-label, Phase 3 efficacy and safety study of L-praziquantel orodispersible tablets (L-PZQ ODT) in Schistosoma-infected children 3 months to 6 years of age, including a 2:1 randomized, controlled cohort of Schistosoma mansoni-infected children 4 to 6 years of age treated with L-PZQ ODT or commercial PZQ (Biltricide®)   
Principal Investigator(s)
1. Maurice Reuben Odiere
Site(s) in Kenya
KEMRI-Centre for Global Health Research (CGHR)
 
View

282.

ECCT/19/03/04   NIFTY
      Non-Inferiority Fractional-Doses Trial For Yellow Fever Vaccine         
Principal Investigator(s)
1. George Warimwe
Site(s) in Kenya
KEMRI Kilifi
 
View

283.

ECCT/19/03/03   Biofire FilmArray Gobal Fever GF Panel
    Clinical Evaluation of the FilmArray Gobal Fever GF Panel   
Principal Investigator(s)
1. JOHN WAITUMBI
Site(s) in Kenya
KEMRI Walter Reed Project USAMRD A/K Kisumu
 
View

284.

ECCT/19/04/01   A study to determine if a new shigella vaccine (Shigella4V) is safe, induces immunity and the best dose among Kenyan infants.
    Safety and immunogenicity of a Shigella-tetravalent bioconjugate vaccine: A phase 1/2 randomized controlled and age descending study including dose finding in 9-month-old infants   
Principal Investigator(s)
1. Mainga Hamaluba
2. Kosgei Josphat
Site(s) in Kenya
1. KEMRI-United States Army Medical Research Unit-Kenya, Kericho (Kericho county)
2. KEMRI Wellcome Trust Research Program-CGMR-C (Kilifi county)
 
View

285.

ECCT/19/03/02   PREVENT TD
    A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg daily or 550 mg twice daily) for Chemoprophylaxis Against Travellers’ Diarrhoea (TD) Among Active Duty Deployed U.S. and British Military Personnel (PREVENT TD)   
Principal Investigator(s)
1. Flynn Alexander
Site(s) in Kenya
Nyati Barracks, British Army Training Unit, Kenya
 
View